{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:40:45Z","timestamp":1785865245277,"version":"3.56.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1097\/ico.0b013e318271cc2a","type":"journal-article","created":{"date-parts":[[2012,11,13]],"date-time":"2012-11-13T13:12:57Z","timestamp":1352812377000},"page":"185-190","source":"Crossref","is-referenced-by-count":18,"title":["The Effect of Topical Infliximab on Corneal Neovascularization in Rabbits"],"prefix":"10.1097","volume":"32","author":[{"given":"Jae Woo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Kun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210204","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1126\/science.2416056","article-title":"A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment.","volume":"230","author":"Crum","year":"1985","journal-title":"Science"},{"key":"R2-14-20210204","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00417-005-0036-1","article-title":". Inhibitory effect of triamcinolone acetonide on corneal neovascularization.","volume":"244","author":"Murata","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R3-14-20210204","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/IAE.0b013e3181e46ad8","article-title":"The effect of methotrexate on corneal neovascularization in rabbits.","volume":"30","author":"Byun","year":"2011","journal-title":"Cornea"},{"key":"R4-14-20210204","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/ICO.0b013e3181b1c82f","article-title":"The effect of subconjunctival combined treatment of bevacizumab and triamcinolone acetonide on corneal neovascularization in rabbits.","volume":"29","author":"Kang","year":"2010","journal-title":"Cornea"},{"key":"R5-14-20210204","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3928\/1542-8877-19981001-09","article-title":". Photodynamic therapy for corneal neovascularization.","volume":"29","author":"Primbs","year":"1998","journal-title":"Ophthalmic Surg Lasers"},{"key":"R6-14-20210204","first-page":"707","article-title":". Animal study of photodynamic therapy with verteporfin in corneal neovascularization.","volume":"46","author":"Nah","year":"2005","journal-title":"J Korean Ophthalmol Soc"},{"key":"R7-14-20210204","first-page":"502","article-title":". Laser photocoagulation of feeder vessels in lipid keratopathy.","volume":"17","author":"Mendelsohn","year":"1986","journal-title":"Ophthalmic Surg"},{"key":"R8-14-20210204","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3341\/kjo.2010.24.4.230","article-title":"The effect of bevacizumab on corneal neo vascularization in rabbits.","volume":"24","author":"Kim","year":"2010","journal-title":"Korean J Ophthalmol"},{"key":"R9-14-20210204","first-page":"18","article-title":". Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization.","volume":"39","author":"Amano","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R10-14-20210204","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0002-9440(10)64643-3","article-title":". CD18 and ICAM-1-dependent corneal neovascularization and inflammation after limbal injury.","volume":"157","author":"Moromizato","year":"2000","journal-title":"Am J Pathol"},{"key":"R11-14-20210204","first-page":"1112","article-title":"Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea.","volume":"40","author":"Edelman","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R12-14-20210204","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/329630a0","article-title":". Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha.","volume":"15","author":"Leibovich","year":"1987","journal-title":"Nature"},{"key":"R13-14-20210204","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1023\/A:1018377621102","article-title":". Lipid hydroperoxide-induced tumor necrosis factor (TNF)-alpha, vascular endothelial growth factor and neovascularization in the rabbit cornea: effect of TNF inhibition.","volume":"1","author":"Ueda","year":"1998","journal-title":"Angiogenesis"},{"key":"R14-14-20210204","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1023\/A:1009010628371","article-title":". Lipid hydroperoxide stimulates retinal neovascularization in rabbit retina through expression of tumor necrosis factor-alpha, vascular endothelial growth factor and platelet-derived growth factor.","volume":"2","author":"Armstrong","year":"1998","journal-title":"Angiogenesis"},{"key":"R15-14-20210204","doi-asserted-by":"crossref","first-page":"H1497","DOI":"10.1152\/ajpheart.00959.2004","article-title":". Anti-tumor necrosis factor-alpha therapies attenuate adaptive arteriogenesis in the rabbit.","volume":"289","author":"Grundmann","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R16-14-20210204","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0016-5085(99)70224-6","article-title":". Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohns ileocolitis.","volume":"116","author":"Baert","year":"1999","journal-title":"Gastroenterology"},{"key":"R17-14-20210204","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(94)90628-9","article-title":". Randomized double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.","volume":"344","author":"Elliott","year":"1994","journal-title":"Lancet"},{"key":"R18-14-20210204","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.preteyeres.2008.11.005","article-title":". Therapeutic monoclonal antibodies in ophthalmology.","volume":"28","author":"Rodrigues","year":"2009","journal-title":"Prog Retin Eye Res"},{"key":"R19-14-20210204","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/112067210401400515","article-title":". Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behcet disease.","volume":"14","author":"Giansanti","year":"2004","journal-title":"Eur J Ophthalmol"},{"key":"R20-14-20210204","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ajo.2008.12.004","article-title":". Intravitreal administration of the anti-tumor necrosis factor agent infliximab for neovascular age-related macular degeneration.","volume":"147","author":"Theodossiadis","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R21-14-20210204","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1167\/iovs.08-3171","article-title":". Dual role of intravitreous infliximab in experimental choroidal neovascularization: effect on the expression of sulfated glycosaminoglycans.","volume":"50","author":"Regatieri","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R22-14-20210204","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/archopht.125.9.1221","article-title":"Intravitreal infliximab and choroidal neovascularization in an animal model.","volume":"125","author":"Olson","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"R23-14-20210204","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ajo.2004.09.058","article-title":"Regression of neovascular age-related macular degeneration following infliximab therapy.","volume":"139","author":"Markomichelakis","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R24-14-20210204","first-page":"2194","article-title":". Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes.","volume":"39","author":"Steen","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R25-14-20210204","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0968-0004(97)01074-8","article-title":"Molecular mechanisms of blood vessel formation.","volume":"22","author":"Bussolino","year":"1997","journal-title":"Trends Biochem Sci"},{"key":"R26-14-20210204","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.285.5425.245","article-title":". Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.","volume":"285","author":"Dawson","year":"1999","journal-title":"Science"},{"key":"R27-14-20210204","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1016\/S0041-1345(98)01365-7","article-title":". Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohns disease: analysis of the mechanism of action predicts utility in other diseases.","volume":"30","author":"Feldman","year":"1998","journal-title":"Transplant Proc"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0b013e318271cc2a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T06:43:01Z","timestamp":1643611381000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201302000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e318271cc2a","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}